Supplemental material
OncoImmunology
Volume 10, 2021 - Issue 1
Open access
3,526
Views
20
CrossRef citations to date
0
Altmetric
Original Research
IgG4 induces tolerogenic M2-like macrophages and correlates with disease progression in colon cancer
Galateja Jordakievaa Department of Physical Medicine, Rehabilitation and Occupational Medicine, Vienna, Austriahttps://orcid.org/0000-0001-5884-8256
, Rodolfo Bianchinib The Interuniversity Messerli Research Institute of the University of Veterinary Medicine, the Medical University of Vienna and the University of Vienna, Unit of Comparative Medicine, Vienna, Austria;c Institute Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Division of Comparative Immunology and Oncology, Medical University of Vienna, Vienna, Austria;https://orcid.org/0000-0003-0351-6937
, Daniel Reichholdd Department of General Surgery, Barmherzige Schwestern Krankenhaus Wien, Vienna, Austria
, Jakob Piehslingerd Department of General Surgery, Barmherzige Schwestern Krankenhaus Wien, Vienna, Austria
, Alina Groschopfb The Interuniversity Messerli Research Institute of the University of Veterinary Medicine, the Medical University of Vienna and the University of Vienna, Unit of Comparative Medicine, Vienna, Austria;c Institute Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Division of Comparative Immunology and Oncology, Medical University of Vienna, Vienna, Austria;;e FH Campus Wien, Department of Health Science, Section of Biomedical Analytics, University of Applied Sciences, Vienna, Austria
, Sebastian A. Jensenf Department of General Surgery, Medical University of Vienna, Vienna, Austria;https://orcid.org/0000-0002-6216-193X
, Ettore Mearinig Department of Surgical and Biomedical Sciences, Urology Clinic of Perugia, University of Perugia, Perugia, Italy;https://orcid.org/0000-0003-1652-2965
, Giuseppe Nocentinih Section of Pharmacology, Department of Medicine, University of Perugia, Perugia, Italyhttps://orcid.org/0000-0002-5209-0488
, Richard Crevennaa Department of Physical Medicine, Rehabilitation and Occupational Medicine, Vienna, Austriahttps://orcid.org/0000-0002-9177-0101
, Gerhard J. Zlabingeri Division of Clinical and Experimental Immunology, Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria;https://orcid.org/0000-0002-7478-4173
, Sophia N. Karagiannisj St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London, London, UK;k Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King’s College London, Guy’s Cancer Centre, London, UKhttps://orcid.org/0000-0002-4100-7810
, Alexander Klausd Department of General Surgery, Barmherzige Schwestern Krankenhaus Wien, Vienna, Austriahttps://orcid.org/0000-0003-3832-6957
& Erika Jensen-Jarolimb The Interuniversity Messerli Research Institute of the University of Veterinary Medicine, the Medical University of Vienna and the University of Vienna, Unit of Comparative Medicine, Vienna, Austria;c Institute Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Division of Comparative Immunology and Oncology, Medical University of Vienna, Vienna, Austria;Correspondence[email protected]
https://orcid.org/0000-0003-4019-5765
show allhttps://orcid.org/0000-0003-4019-5765
Article: 1880687
|
Received 10 Sep 2020, Accepted 20 Jan 2021, Published online: 08 Feb 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.